- July 23, 2020
The Food and Drug Administration (FDA or Agency) is announcing a virtual public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2023 through 2027. The virtual public meeting will be held on July 23, 2020, from 9 a.m. to 2 p.m. For more background information on the meeting or to submit comments, please see the Federal Register notice with assigned docket FDA-2010-N-0128 issued on June 8, 2020.
If you would like to attend the meeting, please register on Eventbrite.
The live virtual public meeting will be webcast at this link: https://collaboration.fda.gov/pdufajuly2020/. If you have not used Adobe Connect before, you will be prompted to download the application in order to join.
|PDUFA VII Meeting Agenda 7-23-20||pdf (143.75 KB)|
|Panel 5 Kathy Giacomini||pdf (161.85 KB)|
|Panel 5 David Ridley||pdf (2.15 MB)|
|Panel 5 Aaron Kesselheim||pdf (286.33 KB)|
|Panel 4 Pharmaceutical Research And Manufacturers Of America||pdf (324.39 KB)|
|Panel 4 Biotechnology Innovation Organization||pdf (147.79 KB)|
|Panel 3 American Medical Association||pdf (153.51 KB)|
|Panel 2 National Organization For Rare Disorders||pdf (1.81 MB)|
|Panel 2 National Health Council||pdf (1.06 MB)|
|Panel 2 Friends Of Cancer Research||pdf (208.19 KB)|
|Panel 1 Public Citizen||pdf (352.13 KB)|
|Panel 1 National Consumers League||pdf (814.89 KB)|
|Panel 1 National Center For Health Research||pdf (258.18 KB)|
|Opening Presentation PDUFA Background And Reauthorization Process||pdf (234.78 KB)|
|Panel 2 Personalized Medicine Coalition||pdf (113.57 KB)|
|Meeting Transcript||pdf (1.58 MB)|